Understanding Cannabis R&D Tax Credits: A Game-Changer for Cannabis Operators

When it comes to reducing tax liability in the cannabis industry, most business owners and advisors are searching for every legal advantage available. One of the most powerful—and often overlooked—tools is the Cannabis R&D Tax Credit. If you’re not tapping into this opportunity for your clients or your own business, you’re potentially leaving tens of thousands of dollars on the table.

What Are Cannabis R&D Tax Credits?

Cannabis R&D Tax Credits are financial incentives designed to reward businesses for investing in research and development. These credits can offset federal and state income taxes, payroll taxes, and in some cases, can be refunded. In general, R&D credits are available to companies that develop or improve products, processes, formulas, or software. For cannabis operators, this might include product formulation, testing new extraction methods, or improving packaging systems.

However, there’s a major caveat: since cannabis is still federally illegal, companies that handle THC-heavy products are typically excluded from federal R&D tax credits. This restriction is why many operators are unaware of their eligibility—especially if their business touches both federally legal (CBD/hemp) and illegal (THC) verticals.

Who Can Qualify?

Thanks to the Agriculture Improvement Act of 2018, businesses dealing exclusively in hemp or CBD products (with less than 0.3% THC) are eligible to claim Cannabis R&D Tax Credits at the federal level. That includes manufacturers, testing labs, CBD wellness product companies, and more. For THC-focused businesses, some states offer their own R&D credit programs, which could present significant savings even if federal credits aren’t available.

Additionally, vertically integrated businesses that operate both hemp and THC product lines may qualify for partial credits. The key is knowing how to segment qualified research activities and expenses to maximize benefits without crossing compliance lines.

Why This Matters for Cannabis Operators

Many cannabis operators are strapped for cash and face enormous tax burdens due to 280E restrictions. Leveraging Cannabis R&D Tax Credits allows eligible businesses to recoup funds and reinvest in critical areas like product innovation, equipment upgrades, and talent acquisition. It’s one of the rare tools available that puts real money back into your business—if you know how to use it properly.

Join Our Free Educational Session

To help operators, accountants, and cannabis professionals navigate this complex but rewarding opportunity, we’re hosting a live session titled “Discussion on R&D Tax Credits for Cannabis Operators” with special guest Tyler Kem.

What You’ll Learn:

• The core qualifications for claiming Cannabis R&D Tax Credits

• Strategies for multi-vertical cannabis businesses to separate qualified R&D activities

• A breakdown of which states offer cannabis-specific R&D credit programs

• Real-world examples of cannabis companies that have successfully claimed these credits

• Compliance pitfalls to avoid when working with tax professionals or filing your own claim

As cannabis continues to evolve from a taboo topic to a sophisticated, science-driven industry, R&D will play a pivotal role in shaping its future. Knowing how to take advantage of Cannabis R&D Tax Credits is no longer optional—it’s essential for staying competitive, compliant, and financially strong.

Don’t miss your chance to learn from industry experts and discover how your business—or your clients’ businesses—can benefit from these valuable tax incentives.

Tyler Kem

SPECIALIZED IN R&D TAX CREDIT CONSULTING

Tyler is a tax professional with eight years of public accounting experience. He has specialized in R&D tax credit consulting for the last five years, starting his own R&D consulting firm in 2018. Tyler enjoys educating CPAs, EAs, CFOs, attorneys, and industry leaders about THE tax credit that can make a difference.‍Favorite thing about working at Strike:“Everyday, I get to speak with the most innovative entrepreneurs, business owners, and CPAs. Because no two businesses are alike, no two R&D tax credit studies are alike!”